Prevalite

Low folate status contributes to elevated homocysteine, a metabolite that has been associated with endothelial dysfunction, arterial stiffness, and a higher risk of stroke and coronary heart disease. Large observational studies consistently show that individuals with higher homocysteine levels have greater rates of cardiovascular events, and folate intake is one of the key nutritional determinants of homocysteine. Clinically, folic acid supplementation (often combined with vitamins B6 and B12) can lower homocysteine and appears to modestly reduce stroke risk in some populations, making the identification and correction of folate deficiency an important part of broader cardiovascular risk reduction.

Vitamin A deficiency can damage the surface of the eye in both children and adults, progressing from dry, uncomfortable eyes and night‑vision problems to xerophthalmia and, in severe cases, permanent blindness if it is missed. Regular vitamin A from food and, when appropriate, thoughtfully used supplements can meaningfully reduce this risk; in one large analysis, children in the highest overall intake group had about a 62 percent lower risk of xerophthalmia than those in the lowest group (multivariate relative risk 0.38, 95 percent confidence interval 0.19–0.74). Vitamin A deficiency and xerophthalmia have been documented not just in low‑resource settings but also in at‑risk children and adults in developed countries, so anyone with unexplained dry eyes, night‑vision changes, or corneal findings should have vitamin A status considered and be referred promptly for ophthalmology review to help protect their sight.

Folate deficiency in the periconceptional period significantly increases the risk of neural tube defects (NTDs) such as spina bifida and anencephaly, because adequate folate is required for proper closure of the embryonic neural tube in the first month of pregnancy. Large observational datasets and randomized trials have shown that appropriate folic acid supplementation before conception and in early pregnancy can reduce NTD risk by roughly 50–70% in the general population, with even greater risk reduction in women with a prior NTD‑affected pregnancy. The practical implication is that all women of childbearing potential, not just those actively planning pregnancy, are typically advised to maintain adequate daily folic acid intake so that red‑cell folate stores are sufficient well before conception occurs.

Low vitamin A status can quietly undermine reproductive health, because vitamin A is deeply involved in egg and sperm development, maintenance of reproductive tissues, and the signaling events that trigger meiosis in both the female and male gonad. Studies in pregnant women in rural South Asia show that bringing vitamin A intake closer to recommended levels markedly reduced, but did not fully eliminate, night blindness during pregnancy and postpartum, suggesting that vitamin A supplementation, alongside other key nutrients, may be required to fully protect maternal vision and status. For individuals with fertility challenges or for pregnant women reporting new night‑vision problems, proactively assessing vitamin A status and considering targeted, evidence‑based supplementation protocols can be an important strategy to improve reproductive outcomes and reduce adverse pregnancy risks

Vitamin A and beta carotene are essential for maintaining the integrity of the cornea and the light-sensing pigments in the retina, so deficiency greatly increases the risk of night blindness and other ocular pathologies. In vitamin A deficient regions, hundreds of thousands of children each year develop xerophthalmia, ranging from conjunctival and corneal dryness to corneal ulceration and keratomalacia, which can progress to irreversible blindness if not corrected. Even subclinical deficiency can impair dark adaptation and increase susceptibility to eye infections, making adequate vitamin A and carotenoid intake a critical foundation for long-term visual health.

Inadequate vitamin D undermines calcium absorption and bone remodeling, so chronic deficiency increases the risk of low bone mineral density, osteoporosis, and osteomalacia with bone pain and muscle weakness. Epidemiologic data have linked low 25‑hydroxyvitamin D levels with higher rates of fragility fractures, particularly hip and vertebral fractures in older adults, even after adjusting for age and baseline bone density. Clinically, correcting vitamin D deficiency, together with adequate calcium intake, resistance exercise, and fall‑prevention strategies, has been shown to improve bone mineral density and help reduce fracture risk in at‑risk populations.